Latest filing published 21 Jun 2022 for Acutus Medical, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Daniella Cramp (board member) discloses dealings in 2 companies, chiefly Alere Inc. and Acutus Medical, Inc. Over a trading history stretching from 30 June 2015 to 16 June 2022, the count stands at 19 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 21 June 2022: a share grant, in Acutus Medical, Inc. Typically, a trade is published a median of 5 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration